Research Article
Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine
Table 1
Patient clinical characteristics.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FAB: French-American-British classification; WBC: white blood cell; Hb: hemoglobin level; Plt: platelet level; FISH: fluorescence in situ hybridization; Flt-3: FMS-like tyrosine kinase 3; ITD: internal tandem duplications; TKD: tyrosine kinase domain; NPM: nucleophosmin; ND: not determined. |